These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1442 related articles for article (PubMed ID: 29355619)

  • 21. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
    Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
    Xu M; Li S
    Cancer Lett; 2023 Oct; 574():216397. PubMed ID: 37730105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging Bio-Nano Science and Cancer Nanomedicine.
    Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
    ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of polymeric nanoparticles in immunotherapy.
    Craparo EF; Bondì ML
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):658-64. PubMed ID: 23095912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.
    Ajorlou E; Khosroushahi AY
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):251-265. PubMed ID: 27744564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
    Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN
    Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkers: The key elements for the creation of efficient nanotherapeutics.
    Hassanzadeh P; Atyabi F; Dinarvand R
    J Control Release; 2018 Jan; 270():260-267. PubMed ID: 29246786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
    Nakamura T
    Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.
    Soetaert F; Korangath P; Serantes D; Fiering S; Ivkov R
    Adv Drug Deliv Rev; 2020; 163-164():65-83. PubMed ID: 32603814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles in oncology: the new theragnostic molecules.
    Allegra A; Penna G; Alonci A; Rizzo V; Russo S; Musolino C
    Anticancer Agents Med Chem; 2011 Sep; 11(7):669-86. PubMed ID: 21787275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Multifunction Smart Nanoparticle based Drug Delivery Systems.
    Fatima H; Naz MY; Shukrullah S; Aslam H; Ullah S; Assiri MA
    Curr Pharm Des; 2022; 28(36):2965-2983. PubMed ID: 35466867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ligand nanoparticle conjugation approach for targeted cancer therapy.
    Karra N; Benita S
    Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.